Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina

American Heart Journal

Volumn 137, Issue 5, 1999, Pages 815-820

  Benamer, Hakim ^a   Steg, Philippe Gabriel ^b   Benessiano, Joelle ^b   Vicaut, Eric ^b   Gaultier, Cedric J ^b   Aubry, Pierre ^b   Boudvillain, Olivier ^b   Sarfati, Laurent ^b   Brochet, Eric ^b   Feldman, Laurent J ^b   Himbert, Dominique ^b   Juliard, Jean Michel ^b   Assayag, Patrick ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY THROMBOSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 0032913311     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70404-7     Document Type: Article

References (34)

1. 1. Mulcahy R, Daly L, Graham I, et al. Unstable angina: natural history and determinants of prognosis. Am J Cardiol 1981;48:525-8.
2. 2. Bugiardini R, Borghi A, Pozzati A, et al. Relation of severity of symptoms to transient myocardial ischemia and prognosis in unstable angina. J Am Coll Cardiol 1995;25:597-604.
3. 3. Bugiardini R, Pozzati A, Borghi A, et al. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Cardiol 1991;67:460-4.
4. 4. Freeman MR, Williams AE, Chisholm RJ, et al. Intracoronary thrombus and complex morphology in unstable angina. Circulation 1989; 80:17-23.
5. 5. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:529-45.
6. 6. Deligonul U, Gabliani G, Coralis D, et al. Percutaneous transluminal coronary angioplasty in patients with intracoronory thrombus. Am J Cardiol 1988;62:474-6.
7. 7. Mabin T, Holmes D, Smith H. Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;5:198-202.
8. 8. Vaitkus P, Herrman H, Laskey W. Management and immediateoutcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 1992;124:1-8.
9. 9. Lincoff A, Popma J, Ellis S, et al. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-35.
10. 10. Musa Khan M, Ellis S, Aguirre F, et al. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. J Am Coll Cardiol 1998;31:31-6.
11. 11. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
12. 12. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
13. 13. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
14. 14. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
15. 15. Jurlander B, Molani MA, Balu D, et al. Serum troponin T levels predict coronary angiographic findings in patients with unstable angina [abstract]. Circulation 1995;92(suppl I):1-679.
16. 16. Simoons ML, Jan de Boer M, van der Brand MJBM, et al, for the European Cooperative Study Group. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. Circulation 1994;89:596-603.
17. 17. Liuzzo G, Biasucci LM, Gillamore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994,331:417-24.
18. 18. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-72.
19. 19. Mach F, Lovis C, Gaspoz J-M, et al. The prognostic value of C-reactive protein in severe unstable angina [abstract]. Circulation 1995; 92(suppl I):1-679.
20. 20. Haverkate F, Thompson SG, Pyke SDM, et al, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349:462-6.
21. 21. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenousstreptokinase: clinical findings through hospital discharge. Circulation 1987;76:142-54.
22. 22. Rupprecht H-J, Terres W, Özbek C, et al. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina. J Am Coll Cardiol 1995; 26:1637-42.
23. 23. Dongas G, Mehran R, Wallenstein S, et al. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol 1997;29:519-25.
24. 24. Sandler H, Dodge HT. The use of a single plane angiocardiograms for the circulation of left ventricular volume in man. Am Heart J 1968;75:325-34.
25. 25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
26. 26. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985;4:699-708.
27. 27. EPIC investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med 1994;330:956-61.
28. 28. Lindahl B, Venge P, Wallentin L, for the Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Troponin T identifies patients with unstable coronary disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997;29:43-8.
29. 29. Ambrose JA, Almeida OD, Sharma SR, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA Trial. Circulation 1994;90:69-77.
30. 30. Kohchi K, Takebayashi S, Hiroki T, et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985;71:709-16.
31. 31. van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
32. 32. Neri Serneri GG, Prisco D, Martini F, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
33. 33. Jude B, Agraou B, McFadden EP, et al. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 1994;90:1662-8.
34. 34. Quillen JE, Rossen JD, Oskarsson HJ, et al. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22:642-7.